Gilead FCA Suit Satisfies Escobar, 9th Circ. Rules
The Ninth Circuit on Friday resurrected a multibillion-dollar False Claims Act suit accusing Gilead Sciences Inc. of defrauding taxpayers by concealing information about drug suppliers and contamination, saying the whistleblower suit...To view the full article, register now.
Already a subscriber? Click here to view full article